J. C. Madelmont

Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).

J. Michelot, Marie‐France Moreau, A. Veyre et al. · PubMed · 1993 · 119 citations

Primary Melanomas, Surgical Oncology, Engineering +15

Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.

J. Michelot, Marie‐France Moreau, P.G. Labarre et al. · PubMed · 1991 · 89 citations

Engineering, Malignant Melanoma, New Iodine-125 Radiopharmaceuticals +18

Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-Diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents

Marie‐France Moreau, J. Michelot, Janine Papon et al. · Nuclear Medicine and Biology · 1995 · 43 citations

Engineering, Preliminary Evaluation, Medicine +11

Higher skeletal muscle protein synthesis and lower breakdown after chemotherapy in cachectic mice

S. E. Samuels, Andrew Llewellyn Knowles, T. Tilignac et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2001 · 37 citations · Full text

Muscle Function, Chemoprevention Strategy, Skeletal Muscle Mass +19

Protein metabolism in the small intestine during cancer cachexia and chemotherapy in mice.

S. E. Samuels, Andrew Llewellyn Knowles, T. Tilignac et al. · PubMed · 2000 · 31 citations

Chemoprevention Strategy, Pathology, Digestive Tract +16